Page last updated: 2024-11-03

probenecid and Glaucoma

probenecid has been researched along with Glaucoma in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferry, AP1
Lichtig, M1

Other Studies

1 other study available for probenecid and Glaucoma

ArticleYear
Gouty arthritis as a complication of acetazolamide (Diamox) therapy for glaucoma.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1969, Volume: 4, Issue:2

    Topics: Acetazolamide; Colchicine; Glaucoma; Gout; Humans; Male; Middle Aged; Probenecid

1969